Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-17-012354

Director acquired 20,777 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Drutz David Director 2017-05-04 Grant or award +20,777 20,777 D
Derivatives
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +4,755 4,755 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +1,791 1,791 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +1,791 1,791 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +2,090 2,090 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +4,178 4,178 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +4,178 4,178 D
Drutz David Director 2017-05-04 Grant or award · Stock Option (option to buy) +4,177 4,177 D
Loading xslF345X03/doc4.xml…